Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Our four decades of clinical trial experience includes the execution and management of programs Phase l-IV in most therapeutic areas, inclusive of novel therapy areas of rare disease and cell & gene therapy. Our operational teams collaborate with sponsors to bring study results to conclusion, efficiently allowing for the meeting of global regulatory submission requirements to support product commercialization goals.
As a founding member of the Decentralized Clinical Trials & Research Association (DTRA), UBC is at the cutting edge of adopting patient-focused, decentralized research methods. These approaches accelerate the collection of critical data and insights needed for regulatory decisions and beyond.
Obtain regulatory approval through innovative research methods. UBC’s decades of experience in strategic clinical development and execution of studies across most therapeutic areas, and around the world, includes:
When it comes to the successful design and implementation of real-world, late phase studies, experience counts. For more than 30 years, UBC leaders have offered scientific and global clinical operations expertise to our research sponsors. Count on UBC to leverage our knowledge and experience in the following to support your strategic and scientific objectives: